Honokiol decreases alpha-synuclein mRNA levels and reveals novel targets for modulating alpha-synuclein expression

Frontiers in aging neuroscience(2023)

Cited 0|Views10
No score
Abstract
Background: Intracytoplasmic inclusions comprised of aggregated alpha-synuclein (alpha syn) represent a key histopathological feature of neurological disorders collectively termed "synucleinopathies," which includes Parkinson's disease (PD). Mutations and multiplications in the SNCA gene encoding alpha syn cause familial forms of PD and a large body of evidence indicate a correlation between alpha syn accumulation and disease. Decreasing alpha syn expression is recognized as a valid target for PD therapeutics, with down-regulation of SNCA expression potentially attenuating downstream cascades of pathologic events. Here, we evaluated if Honokiol (HKL), a polyphenolic compound derived from magnolia tree bark with demonstrated neuroprotective properties, can modulate alpha syn levels in multiple experimental models.Methods: Human neuroglioma cells stably overexpressing alpha syn, mouse primary neurons, and human iPSC-derived neurons were exposed to HKL and alpha syn protein and SNCA messenger RNA levels were assessed. The effect of HKL on rotenone-induced overexpression of alpha syn levels was further assessed and transcriptional profiling of mouse cortical neurons treated with HKL was performed to identify potential targets of HKL.Results: We demonstrate that HKL can successfully reduce alpha syn protein levels and SNCA expression in multiple in vitro models of PD with our data supporting a mechanism whereby HKL acts by post-transcriptional modulation of SNCA rather than modulating alpha syn protein degradation. Transcriptional profiling of mouse cortical neurons treated with HKL identifies several differentially expressed genes (DEG) as potential targets to modulate SNCA expression.Conclusion: This study supports a HKL-mediated downregulation of SNCA as a viable strategy to modify disease progression in PD and other synucleinopathies. HKL has potential as a powerful tool for investigating SNCA gene modulation and its downstream effects.
More
Translated text
Key words
alpha-synuclein (alpha Syn), Parkinson's disease, SNCA, natural compound, polyphenol, therapeutic target
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined